Abrocitinib

Abrocitinib is a medication used to treat moderate-to-severe atopic dermatitis (eczema) in adults. It is a Janus kinase (JAK) inhibitor, which means it works by blocking the action of certain proteins involved in the immune system. Abrocitinib is taken as a pill once a day. Common side effects include upper respiratory tract infections, headache, fatigue, and diarrhea.

Abrocitinib, sold under the brand name Cibinqo, is a medication used to treat atopic dermatitis (eczema) in adults and children aged 12 years and above. Here's a breakdown of its key characteristics:

Type of drug:

  • Janus kinase (JAK) inhibitor: Abrocitinib belongs to a class of medications known as JAK inhibitors, which target specific enzymes called Janus kinases (JAKs) involved in the immune system's inflammatory response.

Conditions treated:

  • Moderate to severe atopic dermatitis: Abrocitinib is indicated for adults and adolescents with moderate to severe atopic dermatitis whose condition is not adequately controlled with topical corticosteroids (steroid creams or ointments) or other traditional therapies.

Mechanism of action:

  • Atopic dermatitis is an inflammatory skin condition characterized by chronic itching, redness, and dry, scaly skin. Abrocitinib works by inhibiting certain JAK enzymes that play a role in the signaling pathways involved in inflammation. By blocking these enzymes, Abrocitinib helps to reduce inflammation and improve symptoms of atopic dermatitis.

Administration:

  • Abrocitinib is administered orally as tablets, typically taken twice daily with or without food.

Important to remember:

  • Abrocitinib is a prescription medication and should only be used under the supervision of a qualified healthcare professional.
  • It is not a cure for atopic dermatitis, but it can help to manage symptoms and improve the quality of life for individuals with the condition.
  • Abrocitinib can cause side effects, including upper respiratory tract infections, headache, nausea, and high blood pressure. It is crucial to discuss the potential risks and benefits with your doctor before starting treatment.

Disclaimer: This information is for general knowledge purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for diagnosis, treatment, and personalized recommendations.

 

Anatomical Therapeutic Chemical Classification
D - Dermatologicals
D11 Other dermatological preparations
D11A Other dermatological preparations
D11AH Agents for dermatitis, excluding corticosteroids
External Links